|

Systems Oncology Approach to Optimize Ovarian Cancer Treatment

RECRUITINGSponsored by University of Helsinki
Actively Recruiting
SponsorUniversity of Helsinki
Started2022-01-01
Est. completion2027-12-31
Eligibility
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06117384

Summary

The overall aim is to identify effective therapeutic strategies to ovarian cancer (OC) using serial tumor, ascites and blood samples, and carry out state-of-the-art sequencing approaches, functional assays and associated bioinformatics to understand mechanisms behind chemoresistance in OC and identify new treatment options for OC patients. In this observational trial, we will systematically collect, analyze and interpret functional, molecular and clinical data from real-world ovarian cancer patients.

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Patients diagnosed with ovarian cancer
* Available tumor tissue/blood samples

Exclusion Criteria:

* Inability to consent to the study

Conditions2

CancerOvarian Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.